We believe that cardiac arrhythmia research is facing a crisis. The sinking trend in the number of basic science investigators and grant applications may signal that the field has reached a critical juncture, a tipping point requiring a significant set of new initiatives. A stagnation in beneficial clinical outcomes from arrhythmia therapy suggests to us that re-orientation of the research and development portfolio is imperative. This will require devising innovative strategies to fund disruptive ideas from promising scientists and re-prioritizing funding to attract scientists from all disciplines to join the field. Our call to action resounds with a sense of urgency; the time to invigorate arrhythmia research with fresh perspectives, robust funding, and collective resolve is now.